BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 999226)

  • 1. [Hyperlipoproteinemias in psoriasis].
    Pfahl F; Rouffy J; Duperrat B; Puissant A
    Ann Dermatol Syphiligr (Paris); 1976; 103(1):15-22. PubMed ID: 999226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum cholesterol and total serum lipids of psoriasis patients in comparison with healthy persons and other diseases].
    Ruhrmann H
    Hautarzt; 1972 Oct; 23(10):451-4. PubMed ID: 5087128
    [No Abstract]   [Full Text] [Related]  

  • 3. [The combination of psoriasis with different types of lipoproteinemias. 2. The characteristics of the dyslipoproteinemias caused by disorders in triacylglyceride transport in psoriasis].
    Keshileva ZB; Kosukhin AB; Polevaia LG
    Vestn Dermatol Venerol; 1990; (5):7-11. PubMed ID: 2402946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
    Sommer DM; Jenisch S; Suchan M; Christophers E; Weichenthal M
    Arch Dermatol Res; 2006 Dec; 298(7):321-8. PubMed ID: 17021763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipoproteinemias in the etiology of inner ear disease.
    Spencer JT
    Laryngoscope; 1973 May; 83(5):639-78. PubMed ID: 4702467
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the association between HLA-DQA1 alleles and environmental factors in psoriasis].
    Wei S; Gao M; Zhang X; Yang S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Dec; 23(6):445-8. PubMed ID: 12667357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis.
    Ucak S; Ekmekci TR; Basat O; Koslu A; Altuntas Y
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):517-22. PubMed ID: 16684277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.
    Chen YJ; Wu CY; Shen JL; Chu SY; Chen CK; Chang YT; Chen CM
    Arch Dermatol; 2008 Dec; 144(12):1571-5. PubMed ID: 19075139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency and distribution of hyperlipoproteinemias in arterial diseases, diabetes, and gout. Results of 20 examinations carried out in a hospital setting].
    Vovan L; Lena D; Colombani V; Magnet C
    Ann Biol Clin (Paris); 1973; 31(2):151-2. PubMed ID: 4749232
    [No Abstract]   [Full Text] [Related]  

  • 10. Psoriasis and diabetes: a population-based cross-sectional study.
    Cohen AD; Dreiher J; Shapiro Y; Vidavsky L; Vardy DA; Davidovici B; Meyerovitch J
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):585-9. PubMed ID: 18331320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type IV hyperlipoproteinaemia. A survey based on 23 cases.
    Christensen NC; Horder M
    Dan Med Bull; 1970 Feb; 17(2):54-9. PubMed ID: 5446368
    [No Abstract]   [Full Text] [Related]  

  • 12. [Total lipid, triglyceride and cholesterol in psoriasis].
    Vedrova IN; Anisova AA; Mikhaĭlova MB
    Vestn Dermatol Venerol; 1981 Sep; (9):4-6. PubMed ID: 7303878
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
    Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
    Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of phenotypic variation in psoriasis as a function of age at onset and family history.
    Stuart P; Malick F; Nair RP; Henseler T; Lim HW; Jenisch S; Voorhees J; Christophers E; Elder JT
    Arch Dermatol Res; 2002 Jul; 294(5):207-13. PubMed ID: 12115023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate metabolism in various types of hyperlipoproteinaemia.
    Romics L; Stützel M; Balázsi I; Varsányi-Nagy M
    Acta Med Acad Sci Hung; 1976; 33(3):225-32. PubMed ID: 1031550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic studies in psoriasis].
    Mordovtsev VN; Sergeev AS; Alieva PM
    Sov Med; 1981; (2):81-5. PubMed ID: 7017956
    [No Abstract]   [Full Text] [Related]  

  • 18. Psoriasis and the metabolic syndrome.
    Cohen AD; Gilutz H; Henkin Y; Zahger D; Shapiro J; Bonneh DY; Vardy DA
    Acta Derm Venereol; 2007; 87(6):506-9. PubMed ID: 17989888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raised blood pressure and psoriasis.
    Preece JF
    J R Coll Gen Pract; 1977 Dec; 27(185):713-5. PubMed ID: 616861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Venous thromboembolic accidents during idiopathic hyperlipaemia].
    De Gennes JL; Ozanne P; Turpin G
    Nouv Presse Med; 1982 May; 11(23):1777-80. PubMed ID: 7099951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.